We have identified a novel network of tumorigenic prognostic factors that plays a critical role in pancreatic cancer (PC) pathogenesis. This interactome is interconnected through a central tumor suppressive microRNA, miR-198, which is able to both directly and indirectly modulate expression of the various members of this network to alter the molecular makeup of pancreatic tumors, with important clinical implications. When this tumor signature network is intact, miR- 
INTRODUCTION
The complex biological functions that give rise to cancer pathogenesis can rarely be attributed to individual molecules, but rather arise from key interactions among heterogeneous components interacting in modular regulatory networks. The result is a specific disease signature with far-reaching clinical effects (1) . MiRNAs are small, non-coding RNA molecules frequently dysregulated in cancers (2) . MiRNAs can individually regulate several links of a functional network; therefore miRNA dysregulation can give rise to a complex disease phenotype (3) . In this study, we have identified a novel network of heterogeneous prognostic factors for pancreatic cancer (PC) interconnected through modulation of a central, tumor-suppressive miRNA, miR-198. These include mesothelin (MSLN), NF-κB, and homeobox transcription factors POU2F2 (OCT-2), Pre-B-cell leukemia homeobox factor 1 (PBX-1), and valosin-containing protein (VCP).
MiR-198 was previously reported to be down-regulated up to 5-fold in hepatic cancers compared to normal liver parenchyma (4) , and was reported as a suppressor of hepatocellular carcinoma cell invasion through negative regulation of the HGF/c-MET pathway (5) . Yet miR-198 was also found to be upregulated in retinoblastoma, indicating that it may not behave as a tumor suppressor in all cases (6) . However, its role in PC pathogenesis has not been studied.
MSLN is a cell surface glycoprotein overexpressed in ~90% of human pancreatic adenocarcinomas (7) (8) (9) (10) . We have reported that MSLN overexpression leads to increased PC cell proliferation, invasion, and migration in vitro and increased tumor growth in vivo (9) , and constitutively activates NF-κB to promote cell survival (11, 12 ). Yet the mechanisms through which MSLN mediates pathogenesis remained largely unexplored. Here, we identify the MSLN-NF-κB axis as part of the interactive network regulating miR-198, along with a molecule whose 6 expression had not been previously observed in PC, OCT-2. OCT-2 is a bi-functional TF that can exert both activating and repressing functions (13) . Its expression was previously thought primarily restricted to B-cells and tumor cells of the B-cell lineage, neuronal cells, and keratinocytes (14) (15) (16) (17) . In this study, we found that OCT-2 is expressed in PC cells, is induced by MSLN, and acts as a regulator of miR-198 activity, leading to dysregulation of downstream effectors PBX-1 and VCP. PBX-1 was initially identified as a participant in pre-B-cell acute lymphoblastic leukemia (18, 19) , and has been associated with progression of melanoma, (20) .
Furthermore, PBX-1 is an inducer of the gene for VCP, a ubiquitously expressed protein involved in cell survival (21) , with prior indications as a prognostic marker for PC metastasis (22) (23) (24) . We found that the PBX-1/VCP axis plays a key role in MSLN-mediated PC pathogenesis.
With miR-198 as a central vantage point, we examined the molecular makeup of heterogeneous patient tumors. We identified a pattern of expression that correlates with decreased tumorigenesis in mice and has clinical relevance with patient prognosis and survival, with implications for both therapeutic intervention and diagnostic applications.
Materials and Methods

Cell lines and cell culture
Human PC cell lines used in this study were purchased from the ATCC and were authenticated by DNA fingerprinting at the University of Texas MD Anderson Cancer Center Characterized Cell Line Core. HPDE cells were provided as a gift from Dr. Ming-Sound Tsao (Ontario Cancer Institute, Canada). All cells were cultured as previously described (8, 9, 25) 
Patient tissue collection and preparation
Human pancreatic adenocarcinoma specimens were collected from the patients of any age, gender, and race who underwent resectable surgery according to an approved human IRB protocol (H-16215) at BCM (Houston, TX). A complete matching set of surrounding normal pancreas, plasma, serum and blood cells from the same patient were also collected and stored at the Elkins Pancreas Center tissue bank. All patient samples used in this study were diagnosed pancreatic adenocarcinoma stages IIA or IIB between ages of 40 to 79. Tissue total RNA isolation was done by using Ambion "RNAqueous-4PCR" kit. Total miRNAs were extracted and purified by using mirVana miRNA isolation kit (Applied Biosystems/Ambion). For detailed method, please see the supplementary experimental procedures.
Subcutaneous and Orthotopic Pancreatic Cancer Mouse Models
Animal procedures were conducted under guidelines approved by the Institutional Animal Care and Use Committee (IACUC). Tumor cells (3 × 10 6 ) were inoculated into the right 
Statistical analysis
Statistical analysis was performed using the Student's t-test (paired, 2-tailed). Statistical significance was defined as p<.05 (denoted by *). Survival data was analyzed using Log-rank test and the data was plotted using the Kaplan-Meier method. Patients still living were censored from the results. In addition, expression values were log2 transformed and Cox proportional hazards model was used to examine the association between the variables and the overall survival. P-values and 95% confidence intervals are two-sided. SAS 9.3 (SAS institute Inc.) was used for statistical analysis. Data are presented as mean ± SD. Linear regression analyses were performed using Prism (GraphPad). Table 2 ). We identified three binding sites for the NF-κB-inducible, repressive transcription factor OCT-2 (consensus sequence ATGCAAAT) in the FSTL1/miR-198 promoter. Figure 1C ). These results were also confirmed in endogenously high MSLN cell line AsPC1 (Supplemental Figure 1E) . Lastly, OCT-2 knockdown with shRNAs resulted in a 12-fold upregulation of miR-198 expression after 72 h, restoring miR-198 levels close to pre-MSLN expression levels ( Figure 1D ). These results demonstrate that MSLN-mediated NF-κB activation induces OCT-2, which in turn represses miR-198. Blocking either NF-κB or OCT-2 in this pathway can effectively restore miR-198 expression.
MiR-198 is the central link between upstream regulatory factors MSLN and OCT-2 and downstream targets, PBX-1 and VCP
We used miRNA target prediction software to find potential miR-198 targets. After screening a wide number of genes using real-time RT-PCR (data not shown), we identified a potential miR-198 binding site within the 3'UTR of PBX-1 (Supplemental Figure 2A ). This binding site is evolutionarily conserved in 22 of 23 species examined (Supplemental Figure 2B ).
PBX-1 has direct effects on tumorigenicity, and is also a regulator of VCP; increased expression of the PBX-1-VCP axis has been associated with cancer metastasis, increased cell survival, and poor prognosis (28) . VCP also has a binding site for miR-198 within its 3'UTR (Supplemental Figure 2C ) that is conserved in a majority of species (Supplemental Figure 2D Figure 5D ).
An interactome of tumorigenic factors interconnected through miR-198 serves as a prognostic indicator of PC
To provide a glimpse into the potential clinical relevance of our in vivo results, we examined expression of network factors in 37 PC patients who underwent resectable surgery at Elkins Pancreas Center. We found that miR-198 was downregulated in ~78% of tumors Table 3 ). We further found that patients could be classified into two groups based on overall tumor miR-198 levels: patients with miR-198 levels of 0.01 or greater (relative to U6 control) were included in the miR-198-High Group; patients with a miR-198 level of 0.001 or lower were included in the miR-198-Low Group. The average relative miR-198 levels were 0.08 and 0.0004, respectively. Therefore, the miR-198-High Group had a minimum ten-fold higher level of miR-198 than the miR-198-Low Group, with the majority of samples having a greater than 100-fold difference between the groups ( Figure 6B ). Table 4 ), while a multivariate approach adjusting for both age and primary tumor size at the time of resection shows that miR-198 is significantly associated with overall survival (p=.0014, 95% Cl of ratio 0.11(0.03,0.42) (Supplemental Table 4 reduced. Loss of miR-198 may be indicative to aggressiveness of pancreatic cancer based on our data obtained from several human pancreatic cancer cell lines, which are commonly used in the scientific community. However, it could be a limitation that we did not include more cell lines such as L3.6pl (30) and SUIT-2 (31) in the current study.
Within this concerted network, we have uncovered a reciprocal regulatory loop between MSLN and miR-198 that gives us novel insight into the mechanisms of MSLN-mediated pathogenesis. MiR-198 can reciprocally target multiple sites in the MSLN coding region, with an additive effect that leads to an almost complete block of MSLN protein expression. We have previously reported that MSLN overexpression leads to constitutive activation of NF-κB, resulting in increased cell survival and proliferation of PC cells through NF-κB-mediated IL-6 induction (11, 12). Here we extend these findings to show that MSLN-mediated NF-κB activation can modulate miR-198 through induction of OCT-2. We have identified OCT-2 as an important factor in PC for the first time. Our findings that OCT-2 is overexpressed in a majority of PC cell lines and is upregulated in over 80% of patient tumor tissues present a novel role for this protein as a PC prognostic factor and functional target.
We also found that miR-198 targets the tumorigenic factors PBX-1 and VCP. PBX-1 dysregulation has been implicated in increased proliferation of cancer cells (20, 32) 
